Barretina, Jordi <br/><br/>
Immunological and virological study of enfuvirtide-treated HIV-positive patients.  [electronic resource] 

 -  AIDS (London, England)  Aug 2004 
 - 1673-82 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0269-9370 
<br/><br/><label>Standard No.: </label>10.1097/01.aids.0000131350.22032.b5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ADP-ribosyl Cyclase--analysis<br/>ADP-ribosyl Cyclase 1<br/>Adult<br/>Antigens, CD--analysis<br/>Apoptosis--drug effects<br/>Biomarkers--analysis<br/>CD4 Lymphocyte Count<br/>Chemokines--analysis<br/>Cytokines--analysis<br/>Drug Resistance, Viral--immunology<br/>Enfuvirtide<br/>HIV Envelope Protein gp41--immunology<br/>HIV Fusion Inhibitors--immunology<br/>HIV Seropositivity--drug therapy<br/>HLA-DR Antigens--analysis<br/>Humans<br/>Lymphocyte Activation--immunology<br/>Membrane Glycoproteins<br/>Microbial Sensitivity Tests<br/>Peptide Fragments--immunology<br/>Receptors, CCR5--analysis<br/>Receptors, CXCR4--analysis<br/>Treatment Outcome<br/>Viral Load